How long does a Wegovy approval last with BCBS Michigan?

Heart Disease Risk Reduction — Applies to Employer and ACA Marketplace plans. Initial approval: 12 months.

What does BCBS Michigan require to renew Wegovy?

Heart Disease Risk Reduction — Applies to Employer and ACA Marketplace plans. At least 5% weight loss from the starting weight. For adults (obesity/CV risk reduction): 5% weight loss from baseline, current weight submission, attestation of continued active participation in lifestyle modifications, BMI ≥ 18.5 kg/m2. CV disease establishment and other initial criteria are not explicitly re-verified at continuation.

How current is this information?

The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

BCBS Michigan coverage for Wegovy (Heart Disease Risk

Does BCBS Michigan cover Wegovy for Heart Disease Risk Reduction?

Yes. BCBS Michigan covers Wegovy for heart disease risk reduction with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

Prior Authorization And Step Therapy Guidelines

BCBS Michigan · PA policy · Employer and ACA Marketplace

Verified June 2, 2026.

View PDF Download Original insurer source

Employer and ACA Marketplace: Covered with requirements. See the qualification pathways below.

Earliest policy review June 2, 2026. How we verify · Check your exact plan

Full requirements: Wegovy for Heart Disease Risk Reduction (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

CV Risk Reduction in Adults with Established CVD and Obesity/Overweight

All of:

Established cardiovascular disease
Obesity (BMI ≥ 30 kg/m2) OR overweight (BMI ≥ 27 kg/m2)
Used in combination with reduced calorie diet and increased physical activity
Current baseline weight documented
Physician attestation that member will participate in lifestyle modifications
Not to be used in combination with other weight loss products
Cannot be used in combination with other GLP-1 agonist-containing products

Documentation to bring

Documentation of established cardiovascular disease
Physician attestation of BMI ≥ 30 kg/m2 (obese) or ≥ 27 kg/m2 (overweight)
Documentation of current baseline weight
Physician attestation of member participation in lifestyle modifications (reduced calorie diet and increased physical activity)
Attestation that medication will not be combined with other weight loss products
Attestation that medication will not be combined with other GLP-1 agonist-containing products
For continuation: Physician attestation that member maintains ≥ 5% weight loss from baseline
For continuation: Current weight submission
For continuation: Attestation of continued active participation in lifestyle modifications
For continuation: BMI ≥ 18.5 kg/m2

Approval and renewal

Initial approval: 12 months
Renewal: At least 5% weight loss from the starting weight.
Renewal: For adults (obesity/CV risk reduction): 5% weight loss from baseline, current weight submission, attestation of continued active participation in lifestyle modifications, BMI ≥ 18.5 kg/m2. CV disease establishment and other initial criteria are not explicitly re-verified at continuation.

Not covered when

Cannot be used in combination with other weight loss products
Cannot be used in combination with other GLP-1 agonist-containing products

Policy note: The CV risk reduction pathway is explicitly listed as a separate qualification route for adults with established cardiovascular disease. The policy does not specify particular CV qualifying events (e.g., MI, stroke, PAD) beyond 'established cardiovascular disease.' No exclusion of patients with diabetes is stated. Continuation uses the same criteria as the obesity/overweight continuation pathway (5% weight loss from baseline).

Policy effective June 1, 2026 · verified June 2, 2026 · source: Prior Authorization And Step Therapy Guidelines · View policy document (PDF)

Open on its own page →

Questions people ask

Does BCBS Michigan cover Wegovy?: Yes. BCBS Michigan covers Wegovy for heart disease risk reduction with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
How long does a Wegovy approval last with BCBS Michigan?: Heart Disease Risk Reduction — Applies to Employer and ACA Marketplace plans. Initial approval: 12 months.
What does BCBS Michigan require to renew Wegovy?: Heart Disease Risk Reduction — Applies to Employer and ACA Marketplace plans. At least 5% weight loss from the starting weight. For adults (obesity/CV risk reduction): 5% weight loss from baseline, current weight submission, attestation of continued active participation in lifestyle modifications, BMI ≥ 18.5 kg/m2. CV disease establishment and other initial criteria are not explicitly re-verified at continuation.
How current is this information?: The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Summary of BCBS Michigan's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.